Home・Akciju saraksts・West Pharmaceutical Services Inc

West Pharmaceutical Services Inc

Slēgts

SektorsVeselības aprūpe

348.47 0.18

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

340.33

Max

349.24

Galvenie mērījumi
By Trading Economics
Ienākumi	15M 154M
Pārdošana	27M 872M
P/E Sektora vidējais	42.414 64.641
EPS	2.37
Dividenžu ienesīgums	0.27
Peļņas marža	17.654
Darbinieki	10,800
EBITDA	-39M 179M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+18.42% upside

Dividendes
By Acuity
Dividenžu ienesīgums Sektora vidējais	0.27% 2.31%
Nākamie ieņēmumi	2026. g. 22. okt.
Nākamais dividenžu datums	2026. g. 5. aug.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-1.6B 23B
Iepriekšējā atvēršanas cena	348.29
Iepriekšējā slēgšanas cena	348.47

Ziņu noskaņojums

By Acuity

50%

132 / 340 Rangs Healthcare

West Pharmaceutical Services Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 31. jūl. 23:01 UTC

News

West Pharmaceutical Services shares are lower in after-market trading despite strong Q2 results and raised full-year guidance, reflecting mixed market sentiment.

2026. g. 29. jūl. 19:44 UTC

Macro Event

West Pharmaceutical Services is slightly lower amid broader market declines following the Federal Reserve's decision to keep interest rates steady.

2026. g. 28. jūl. 23:31 UTC

West Pharmaceutical Services shares declined in after-market trading, tracking broader market losses amid rising competition in the semiconductor sector.

2026. g. 27. jūl. 19:41 UTC

News

Evercore ISI raised its price target on West Pharmaceutical Services to $425, contributing to positive sentiment as shares trade higher since Friday's close.

2026. g. 24. jūl. 22:01 UTC

West Pharmaceutical Services Inc shares are lower in after-market hours, continuing a trend of recent declines despite earlier volatility during the session.

2026. g. 22. jūl. 22:51 UTC

West Pharmaceutical Services Inc shares are trading higher in after-market hours, supported by strong performance relative to their 20-day moving average and one-month range.

2026. g. 21. jūl. 19:46 UTC

News

West Pharmaceutical Services has secured long-term agreements with Daikyo Seiko, enhancing its global reach. Shares are trading higher amid positive market momentum.

2026. g. 20. jūl. 19:16 UTC

West Pharmaceutical Services is lower today, influenced by a notable decline in the Life Sciences Tools & Services sub-sector. No specific news was identified.

Salīdzinājums

Cenas izmaiņa

West Pharmaceutical Services Inc Prognoze

Cenas mērķis

By TipRanks

18.42% augšup

Prognoze 12 mēnešiem

Vidējais 403.78 USD 18.42%

Augstākais 447 USD

Zemākais 365 USD

Pamatojoties uz 10 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi West Pharmaceutical Services Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

10 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 10 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam West Pharmaceutical Services Inc — pēdējo 3 mēnešu laikā.

Noskaņojums

By Acuity

132 / 340 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.